Cardiac Glycosides has 23 known drug interactions based on U.S. FDA drug labeling data. 12 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Adrenalin (Epinephrine), Albuterol Sulfate, Auvi-Q. Patients taking Cardiac Glycosides should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 23
- Major
- 12
- Moderate
- 11
Major (12)
- Cardiac Glycosides + Adrenalin (Epinephrine)— Patients receiving cardiac glycosides should be observed carefully for development of cardiac arrhythmias.
- Cardiac Glycosides + Albuterol Sulfate— Patients receiving epinephrine with cardiac glycosides should be observed carefully for development of cardiac arrhythmi…
- Cardiac Glycosides + Auvi-Q— Increased risk of cardiac arrhythmias when used with epinephrine; careful observation required.
- Cardiac Glycosides + Calcium Gluconate— Synergistic arrhythmias may occur if calcium and cardiac glycosides are administered together. Hypercalcemia increases r…
- Cardiac Glycosides + Epinephrine— Potentiate arrhythmogenic effects of epinephrine; observe carefully for cardiac arrhythmias.
- Cardiac Glycosides + Epinephrine 0.15 Pediatrics— Patients receiving epinephrine with cardiac glycosides should be observed carefully for development of cardiac arrhythmi…
- Cardiac Glycosides + Epinephrine 0.3 Adults— Patients receiving epinephrine with cardiac glycosides should be observed carefully for development of cardiac arrhythmi…
- Cardiac Glycosides + Epinephrine In Sodium Chloride— Increase the arrhythmogenic potential of epinephrine; patients should be observed carefully for cardiac arrhythmias.
- Cardiac Glycosides + Magnesium Sulfate Heptahydrate— Serious changes in cardiac conduction and heart block may occur in digitalized patients; administer with extreme caution…
- Cardiac Glycosides + Magnesium Sulfate In Dextrose— Serious cardiac conduction changes and heart block may occur in digitalized patients; use with extreme caution.
- Cardiac Glycosides + Midodrine Hydrochloride— May enhance or precipitate bradycardia, A.V. block or arrhythmia when administered concomitantly with midodrine hydrochl…
- Cardiac Glycosides + Minocycline Hydrochloride— Potentially serious drug interactions may occur when intravenous magnesium sulfate is given concomitantly with cardiac g…
Moderate (11)
- Cardiac Glycosides + Adenosine— Given with adenosine without apparent adverse interactions, but adenosine should be used with caution due to potential a…
- Cardiac Glycosides + Apraclonidine— Caution advised as apraclonidine may reduce pulse and blood pressure.
- Cardiac Glycosides + Brimonidine— Alpha-2 agonists may reduce blood pressure; caution advised when using cardiac glycosides concurrently.
- Cardiac Glycosides + Brimonidine Tartrate— Brimonidine tartrate may reduce blood pressure; caution is advised when used with cardiac glycosides due to potential ad…
- Cardiac Glycosides + Brimonidine Tartrate And Timolol Maleate— May lower blood pressure; caution advised when used with COMBIGAN.
- Cardiac Glycosides + Brimonidine Tartrate Ophthalmic Solution, 0.15%— Brimonidine may reduce blood pressure; caution is advised when used with cardiac glycosides due to potential additive hy…
- Cardiac Glycosides + Brinzolamide/Brimonidine Tartrate— Brimonidine may reduce blood pressure; caution advised when used with cardiac glycosides.
- Cardiac Glycosides + Carbachol And Brimonidine Tartrate— Cardiac glycosides may lower blood pressure when used with brimonidine tartrate component. Caution advised.
- Cardiac Glycosides + Ephedrine Sulfate— May increase possibility of arrhythmias. Carefully monitor patients receiving both drugs.
- Cardiac Glycosides + Oxymetazoline Hydrochloride— Alpha-adrenergic agonists may impact blood pressure; caution advised when used with cardiac glycosides.
- Cardiac Glycosides + Oxymetazoline Hydrochloride Ophthalmic— Alpha-adrenergic agonists may impact blood pressure; caution advised when using cardiac glycosides concurrently.